Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT06944236

CKM Syndrome Prevalence and Its Association With SCORE-2 and BRI

Sponsor: University of Gaziantep

View on ClinicalTrials.gov

Summary

This cross-sectional study aims to determine the prevalence of Cardiovascular-Kidney-Metabolic (CKM) syndrome in a community-based adult population in Gaziantep, Türkiye. In addition to estimating the prevalence across CKM stages, the study investigates the associations between CKM syndrome and two key risk indicators: the SCORE-2 cardiovascular risk score and Body Roundness Index (BRI). Findings from this study will provide valuable insights into early cardiometabolic risk profiling and support the development of regionally tailored prevention strategies.

Official title: Prevalence of Cardiovascular-Kidney-Metabolic (CKM) Syndrome and Its Relationship With SCORE-2 Risk Score and Body Roundness Index (BRI): A Study From Gaziantep, Turkey

Key Details

Gender

All

Age Range

30 Years - 79 Years

Study Type

OBSERVATIONAL

Enrollment

400

Start Date

2025-06-01

Completion Date

2025-12-31

Last Updated

2025-04-25

Healthy Volunteers

No

Interventions

OTHER

No intervention is applied. This is a non-interventional, observational study. Anthropometric measurements and existing laboratory data are used for CKM staging and risk assessment.

No intervention is applied. This is a non-interventional, observational study. Anthropometric measurements and existing laboratory data are used for CKM staging and risk assessment.

Locations (1)

Bağlarbaşı Family Health Center

Gaziantep, Turkey (Türkiye)